Director of Finance-BioPharma

Interim Director of Finance - Manufacturing

Director of Finance-BioPharma

reporting visibility
The interim completed the P&L project providing critical information to senior management necessary to plan and execute a cost restructuring. Also, we had a positive realignment among the functional departments as a result of the new information the interim provided.
Company Profile
Publicly traded company
Biopharma Manufacturing
> $1 billion in revenues
Interim Director of Finance
2 months
Company had agressive goals for increasing revenue
Ambitious plan for developing numerous new products
Development costs skyrocketed and affected EBITDA but no visibility to full impact
Created a complex matrix and designed a control program to forecast & track expenses
Created detailed forecast P&L and YTD actual per project
Redesigned reporting to faciliate population of forecast and actual figures
Trained staff for on-going accuracy of reporting


  • Top management of corporation now have full visibility
  • Flexible reporting model to help assure EBITDA goals will be attained